Synapse Biomedical Revenue and Competitors

Oberlin, OH USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Synapse Biomedical's estimated annual revenue is currently $9.3M per year.(i)
  • Synapse Biomedical's estimated revenue per employee is $251,000

Employee Data

  • Synapse Biomedical has 37 Employees.(i)
  • Synapse Biomedical grew their employee count by 6% last year.

Synapse Biomedical's People

NameTitleEmail/Phone
1
VP Product Development/OperationsReveal Email/Phone
2
VP QualityReveal Email/Phone
3
Director Quality & Regulatory AffairsReveal Email/Phone
4
Director OperationsReveal Email/Phone
5
Clinical Services ManagerReveal Email/Phone
6
CEO/PresidentReveal Email/Phone
7
COO/Managing Director-EuropeReveal Email/Phone
8
Manufacturing Engineer/IT SupportReveal Email/Phone
9
Principal Mechanical EngineerReveal Email/Phone
10
Clinical Support SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$470.6M18751%N/AN/A
#2
$16.3M65-2%N/AN/A
#3
$7.8M310%N/AN/A
#4
$3.8M150%N/AN/A
#5
$21.1M844%N/AN/A
#6
$70M2798%N/AN/A
#7
$4M16-11%N/AN/A
#8
$135.3M5390%N/AN/A
#9
$11.5M465%N/AN/A
#10
$8.8M3535%N/AN/A
Add Company

What Is Synapse Biomedical?

Synapse Biomedical Inc (SBI) was founded in September 2002 to commercialize the NeuRx Diaphragm Pacing System (DPS)® that has been developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in the state of the art of electrical stimulation for the treatment of chronic respiratory insufficiency. This innovation allows the technology to meet clinical needs, beyond the ability of the currently available systems, in Spinal Cord Injuries, in the diaphragm conditioning in muscular dystrophies (such as ALS) and in respiratory short-term intensive care settings.

keywords:N/A

N/A

Total Funding

37

Number of Employees

$9.3M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Synapse Biomedical News

2022-04-17 - Global Neuromodulation Devices And Implantable Infusion ...

... Implantable Infusion Pumps Market 2022 Industry Development – Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation.

2022-04-17 - Sacral Nerve Stimulation Market Size And Forecast | Nuvectra ...

... Technologies Inc., Nevro Corp., Boston Scientific Corporation, Synapse Biomedical Inc., St. Jude Medical Inc, Johnson and Johnson.

2022-04-17 - Global Diaphragm Pacing Device Market 2022 Growth ...

Product Application. SCI, ALS, Other. Classified into key participants. Avery Biomedical Devices, Synapse Biomedical, Atrotech, Arahelio,.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A379%N/A
#2
N/A3841%N/A
#3
$10.8M500%N/A
#4
$8.3M519%N/A
#5
$11.2M69-3%N/A